INDEXED IN WEB OF SCIENCE AND SCOPUS INDEXED IN PUBMED CENTRAL
Urology Research & Practice
  1. Home
  2. Effect of the COVID-19 Pandemi...
UROONCOLOGY - Original Article

Effect of the COVID-19 Pandemic on Radical Prostatectomy: A Turkish Multicenter Study

Abdullah Gurel 1 , Burhan Baylan 1 , Ibrahim Keles 1 , Arif Demirbas 1 , Mustafa Karalar 1 , Berkay Eren 1 , Ata Ozen 2 , Unal Oztekin 3 , Can Benlioglu 4 , Ahmet Emin Dogan 5 , Mehmet Altan 5 , Erol Ersekerci 6 , Eren Cengiz 7 , Mert Ali Karadag 7 , Ahmet Yaser Müslümanoğlu 8
1.

Department of Urology, Afyon Health Sciences University Faculty of Medicine, Afyon, Turkey

2.

Department of Urology, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey

3.

Department of Urology, Kayseri System Hospital, Kayseri, Turkey

4.

Department of Urology, Adıyaman University Faculty of Medicine, Adıyaman, Turkey

5.

Health Sciences University, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Urology Clinic, Ankara, Turkey

6.

Department of Urology, Kırşehir Ahi Evran University Faculty of Medicine, Kırşehir, Turkey

7.

Kayseri City Education and Research Hospital, Kayseri, Turkey

8.

Department of Urology, Health Sciences University, Bağcılar Training and Research Hospital, İstanbul Turkey

Urol Res Pract 2022; 48: 339-345
DOI: 10.5152/tud.2022.22130
Keywords : COVID-19, prostate cancer, radical prostatectomy, upgrading
Read: 971 Downloads: 381 Published: 01 September 2022
Volume 48, Issue 5, September 2022
Previous Article Next Article

Objective: The present study examines the effects of the coronavirus disease 2019 pandemic on radical prostatectomy performed as part of localized prostate cancer treatment in Turkey.

Material and methods: A retrospective analysis was made of the data of 176 patients from 8 centers in Turkey who underwent radical prostatectomy due to localized prostate cancer over the 2 years spanning March 1, 2019, to February 28, 2021. Within this timeframe, March 1, 2019, to February 28, 2020, was denoted the 1-year pre-coronavirus disease 2019 period, while March 1, 2020, to February 28, 2021, was denoted the 1-year coronavirus disease 2019 period. An analysis was made of whether there was a difference in the number of radical prostatectomies performed for prostate cancer, the time from biopsy to operation, and the biopsy and radical prostatectomy pathology between the 2 periods.

Results: It was found that the number of radical prostatectomies performed for localized prostate cancer during the coronavirus disease 2019 pandemic was statistically and highly significantly fewer than in the pre-coronavirus disease 2019 period (P <.001). The patients diagnosed with Gleason 3+3 (low risk) prostate cancer were statistically significantly fewer in number in the coronavirus disease 2019 period (P <.001). The pathological Gleason score was upgrading than the biopsy Gleason score in all patients who underwent in both periods (P <.001). When the periods were compared, the pathological involvement determined by lymph node dissection performed during radical prostatectomy was found to be decreased in the coronavirus disease 2019 period, although the difference was not statistically significant (P =.051).

Conclusion: As with many diseases, the diagnosis and treatment of prostate cancer have been adversely affected by the coronavirus disease 2019 pandemic.

Cite this article as: Gurel A, Baylan B, Keles I, et al. Effect of the COVID-19 pandemic on radical prostatectomy: A Turkish multicenter study. Turk J Urol. 2022;48(5):339-345.

Files
Full Text PDF
EISSN 2980-1478